Treatment of early disease, when cancer is confined to the original site, is focused on that single area, most often with surgery or radiation therapy. Treatment of advanced disease, when it has ...

Then, last December, the Food and Drug Administration approved a $3.1 million sickle cell gene therapy by Bluebird Bio of Somerville, Mass., and a $2.2 million treatment by Vertex Pharmaceuticals ...

“We’ve been looking for years in ways we can incorporate immunotherapy into the use of cervical cancer [treatments] because we all believe that cervical cancer should have an immune therapy ...